PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1455678
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1455678
Bilevel Positive Airway Pressure (BiPAP) Market size was valued at USD 2,457.72 Million in 2023, expanding at a CAGR of 8.4% from 2024 to 2032.
Bilevel Positive Airway Pressure (BiPAP) devices serve as medical apparatus utilized in treating respiratory ailments like sleep apnea and respiratory failure. These devices administer pressurized air through a mask into the patient's airways, providing dual pressure levels: a higher level during inhalation (known as inspiratory positive airway pressure, IPAP) and a lower level during exhalation (expiratory positive airway pressure, EPAP). This mechanism aids in sustaining an open airway, enhancing oxygenation, and alleviating the respiratory workload. BiPAP devices offer a more tailored approach in comparison to Continuous Positive Airway Pressure (CPAP) devices, rendering them suitable for patients with intricate respiratory requirements or those encountering difficulties with CPAP therapy.
Bilevel Positive Airway Pressure (BiPAP) Market- Market Dynamics
Escalating economic strain and healthcare industry challenges stemming from the rising incidence of obstructive sleep apnea to propel market demand
The escalating economic strain and healthcare industry challenges stemming from the rising incidence of obstructive sleep apnea are propelling the adoption of positive airway pressure (PAP) devices worldwide. According to estimates by the American Academy of Sleep Medicine in 2016, the economic burden attributable to undiagnosed and untreated sleep apnea in the U.S. amounted to approximately USD 149.6 billion, whereas treated cases of sleep apnea could potentially save the U.S. an estimated USD 100 billion annually. Obstructive sleep apnea manifests as a respiratory disorder characterized by irregular breathing patterns leading to diminished oxygen delivery to the brain. As per Up-To-Date estimates on the global prevalence of obstructive sleep apnea released in June 2022, approximately 936 million individuals suffer from mild to severe sleep apnea, with 425 million individuals in the 30 to 69 age group experiencing moderate to severe sleep apnea. Factors such as rapid globalization, shifting lifestyles, and unhealthy dietary habits contribute significantly to the prevalence of sleep apnea. Furthermore, the increasing rates of obesity and sedentary lifestyles further fuel the incidence of obstructive sleep apnea.
Bilevel Positive Airway Pressure (BiPAP) Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.4% over the forecast period (2024-2032)
Based on product type segmentation, CPAP was predicted to show maximum market share in the year 2023
Based on Indication segmentation, obstructive sleep apnea was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Bilevel Positive Airway Pressure (BiPAP) Market is segmented on the basis of Product type, End use, Indication, and Region.
The market is divided into three categories based on product type: CPAP, APAP and BiPAP. The Continuous Positive Airway Pressure (CPAP) devices segment asserted its dominance in the market share in 2023, poised for further substantial growth at a significant CAGR throughout the forecast period. This expansion is attributed to the escalating global incidence rate of obstructive sleep apnea, coupled with heightened awareness among healthcare professionals regarding available treatment modalities. Additionally, the proliferation of market entrants and heightened emphasis on innovative product development strategies aimed at delivering technologically advanced devices are catalyzing this growth trajectory. Shifts in lifestyle patterns and increasing disposable income levels further bolster the CPAP market's expansion, with CPAP devices serving as the primary treatment modality for obstructive sleep apnea and snoring, offering a more cost-effective option compared to other Positive Airway Pressure (PAP) devices.
The market is divided into three categories based on Indication: Obstructive Sleep Apnea, Respiratory Failures and COPD. In terms of indication, the obstructive sleep apnea segment secured the largest market share in 2023, driven by the escalating prevalence of sleep disorders, particularly sleep apnea. This trend is anticipated to persist, fueled by the increasing awareness surrounding the adverse consequences of untreated sleep disorders. The market for devices and treatments addressing sleep apnea is slated to witness substantial growth in the coming years, propelled by the surge in prevalence of sleep apnea and other sleep-related disorders, alongside a heightened awareness regarding the detrimental impacts of untreated sleep disorders. Market advancements in sleep apnea devices are driving market evolution, with manufacturers introducing novel, technologically advanced, and portable devices aimed at enhancing patient comfort and convenience. Notably, the availability of wireless and battery-powered devices enables patients to utilize the devices while traveling or in situations where access to a power outlet is limited.
Bilevel Positive Airway Pressure (BiPAP) Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Within the BiPAP devices market, companies are deploying diverse strategies aimed at augmenting product effectiveness, patient comfort, and market outreach. These initiatives encompass continuous research and development endeavors aimed at refining device design, functionality, and user-friendliness. Moreover, companies are concentrating on introducing innovative features such as auto-adjusting pressure algorithms, wireless connectivity for remote monitoring, and advanced mask technologies to optimize therapeutic outcomes and bolster patient adherence. Additionally, marketing endeavors are directed towards healthcare professionals and patients, aiming to heighten awareness regarding the advantages of BiPAP therapy, thereby fostering heightened adoption rates and market expansion.
In February 2021, Philips and the Dutch SAZ group forged a strategic alliance to provide a comprehensive array of monitoring, observation, and self-management services to individuals diagnosed with obstructive sleep apnea.
GLOBAL BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Philips Respironics
Fisher & Paykel Healthcare Ltd.
Curative Medical Inc.
ResMed
Drive Devilbliss Healthcare Ltd.
Medtronic, Inc.
Servona GmbH
Armstrong Medical
Medical Depot Inc
Smiths Group PLC
Lowenstein Medical UK Ltd
Others